347 related articles for article (PubMed ID: 12571793)
1. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Plikat K; Reichle A; Elmlinger MW; Schölmerich J
Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
[TBL] [Abstract][Full Text] [Related]
3. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
Daughaday WH; Trivedi B; Baxter RC
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
[TBL] [Abstract][Full Text] [Related]
6. Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.
Jannin A; Espiard S; Benomar K; Do Cao C; Mycinski B; Porte H; D'Herbomez M; Penel N; Vantyghem MC
Ann Endocrinol (Paris); 2019 Feb; 80(1):21-25. PubMed ID: 29555080
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
Chung J; Henry RR
J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
[TBL] [Abstract][Full Text] [Related]
8. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II-producing intra-abdominal hemangiopericytoma associated with hypoglycemia.
Matsuda S; Usui M; Sakurai H; Suzuki H; Ogura Y; Shiraishi T
J Gastroenterol; 2001 Dec; 36(12):851-5. PubMed ID: 11777215
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
van Doorn J; van de Hoef W; Dullaart RP
Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
[TBL] [Abstract][Full Text] [Related]
12. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
Hunter SJ; Daughaday WH; Callender ME; McKnight JA; McIlrath EM; Teale JD; Atkinson AB
Clin Endocrinol (Oxf); 1994 Sep; 41(3):397-401; discussion 402. PubMed ID: 7525121
[TBL] [Abstract][Full Text] [Related]
13. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
Daughaday WH; Kapadia M
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
[TBL] [Abstract][Full Text] [Related]
15. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia.
Baxter RC
Horm Res; 1996; 46(4-5):195-201. PubMed ID: 8950621
[TBL] [Abstract][Full Text] [Related]
16. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
Zapf J; Futo E; Peter M; Froesch ER
J Clin Invest; 1992 Dec; 90(6):2574-84. PubMed ID: 1281841
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
Mohnike KL; Kluba U; Mittler U; Aumann V; Vorwerk P; Blum WF
Eur J Pediatr; 1996 Feb; 155(2):81-6. PubMed ID: 8775218
[TBL] [Abstract][Full Text] [Related]
18. Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors.
Møller N; Frystyk J; Skjaerbaek C; Pedersen HB; Christensen C; Schmitz O; Gee A; Gjedde A; Zapf J; Orskov H
Diabetologia; 1996 Dec; 39(12):1534-5. PubMed ID: 8960839
[No Abstract] [Full Text] [Related]
19. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.
Teale JD; Wark G
Clin Endocrinol (Oxf); 2004 Apr; 60(4):457-60. PubMed ID: 15049960
[TBL] [Abstract][Full Text] [Related]
20. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
